Skip NavigationSkip to Content
Return Return to Search Results

The hollow fibre model in cancer drug screening: the NCI experience

  1. Author:
    Decker, S.
    Hollingshead, M.
    Bonomi, C. A.
    Carter, J. P.
    Sausville, E. A.

  2. Author Address

    Sausville, EA, NCI, Div Canc Treatment & Diagnosis, Dev Therapeut Program, 6130 Execut Blvd,Room 8018, Rockville, MD 20852 USA NCI, Div Canc Treatment & Diagnosis, Dev Therapeut Program, Rockville, MD 20852 USA. SAIC, Frederick, MD 21701 USA.
    1. Year: 2004
  2. Journal: European Journal of Cancer
    1. 40
    2. 6
    3. Pages: 821-826
  4. Type of Article: Article
  1. Abstract:

    The in vivo hollow fibre model was developed by the National Cancer Institute (NCI) in the United States of America (USA) at a time when the number of potential anti-cancer drugs arising from in vitro screening efforts exceeded the available capacity for testing in traditional xenograft models. Updated analysis of the predictive value of the hollow fibre model continues to indicate that the greater the response in the hollow fibre assay, the more likely it is that activity will be seen in subsequent xenograft models. The original 12 cell line hollow fibre panel has been Supplemented with histology-specific panels, and we begin here to analyse their utility in predicting activity in subsequent in vivo models. The key goal of using the hollow fibre model as a way to decrease the cost, both financial and in the number of animals used, to evaluate initial evidence of a compound's capacity to act across physiological barriers continues to be reinforced With our enlarging experience. (C) 2004 Elsevier Ltd. All rights reserved

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel